AndreaBozzo/ceres-open-data-index huggingface dataset:
Drug Reference Vocabulary - Multum License Agreement

License for the Drug Abuse Warning Network\'s Drug Reference Vocabulary (DRV), a classification system for the substances collected by DAWN that is based on the Multum Lexicon, © 2012 Lexi-Comp, Inc. and/or Cerner Multum, Inc. to meet DAWN\'s unique requirements.  The Lexicon classification was modified to meet DAWN\'s unique requirements.
Compound 525489: Allyl 1,1-dimethylpropyl sulfide

Chemical compound data from PubChem database. IUPAC Name: 2-methyl-2-prop-2-enylsulfanylbutane. Molecular Formula: C8H16S. Molecular Weight: 144.28. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 529746: 1-Ethylundecyl octanoate

Chemical compound data from PubChem database. IUPAC Name: 3-ethylsulfanyl-2-methylfuran. Molecular Formula: C7H10OS. Molecular Weight: 142.22. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Patent AT-E399903-T1: [Translated] METHOD FOR FASTENING A TRAFFIC CONTROL DEVICE TO AN ASPHALT ROAD SURFACE

In a process to fix a road crash barrier (9) to the road surface, the L-shaped crash barrier base (9, 10) is attached to the road surface (18) by a hexagonal bolt (13) with a threaded shank (14) and washer (12). The bolt has a core diameter DK, a thread diameter DG, and a screw-depth of LE. The screw enters the asphalt to a depth of LB where it is anchored in the hole (7) by a fluid mass (8) to a depth of LF. The installation is described by the relationship: DB DG, DB DK, LB LE and O, 2 LE 0.8 LE. The bolt is anchored in a hardened bonding agent which penetrates into surrounding pores.
Compound 525579: N,N-Dimethyl-N'-(3-methylphenyl)-p-chlorobenzamidine

Chemical compound data from PubChem database. IUPAC Name: 4-chloro-N,N-dimethyl-N'-(3-methylphenyl)benzenecarboximidamide. Molecular Formula: C16H17ClN2. Molecular Weight: 272.77. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Compound 529025: 2,4,6,10-Dodecatetraene

Chemical compound data from PubChem database. IUPAC Name: dodeca-2,4,6,10-tetraene. Molecular Formula: C12H18. Molecular Weight: 162.27. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Notice of biennial publication of allotment percentages for States under the Title IV–B subpart 1, Stephanie Tubbs Jones Child Welfare Services Program (Volume 83, Number 230)

Notice of biennial publication of allotment percentages for States under the Title IV–B subpart 1, Stephanie Tubbs Jones Child Welfare Services Program
  
  

 (PDF) - This notice from the Federal Register announces the allotment percentage for fiscal years 2020 and 2021 for each state under the Stephanie Tubbs Jones Child Welfare Services Program authorized by title IV-B, subpart 1 of the Social Security Act (the Act). The allotment percentages are one of the factors used in the computation of the federal grants awarded under the program. The law requires the Department of Health and Human Services to publish the allotment percentages every two years.

Metadata-only record linking to the original dataset. Open original dataset below.
Plasma lipases and lipid transfer proteins increase phospholipid but not free cholesterol transfer from lipid emulsion to high density lipoproteins.

Background
          Plasma lipases and lipid transfer proteins are involved in the generation and speciation of high density lipoproteins. In this study we have examined the influence of plasma lipases and lipid transfer protein activities on the transfer of free cholesterol (FC) and phospholipids (PL) from lipid emulsion to human, rat and mouse lipoproteins. The effect of the lipases was verified by incubation of labeled (3H-FC,14C-PL) triglyceride rich emulsion with human plasma (control, post-heparin and post-heparin plus lipase inhibitor), rat plasma (control and post-heparin) and by the injection of the labeled lipid emulsion into control and heparinized functionally hepatectomized rats.
        
        
          Results
          In vitro, the lipase enriched plasma stimulated significantly the transfer of 14C-PL from emulsion to high density lipoprotein (p<0.001) but did not modify the transfer of 3H-FC. In hepatectomized rats, heparin stimulation of intravascular lipolysis increased the plasma removal of 14C-PL and the amount of 14C-PL found in the low density lipoprotein density fraction but not in the high density lipoprotein density fraction. The in vitro and in vivo experiments showed that free cholesterol and phospholipids were transferred from lipid emulsion to plasma lipoproteins independently from each other. The incubation of human plasma, control and control plus monoclonal antibody anti-cholesteryl ester transfer protein (CETP), with 14C-PL emulsion showed that CETP increases 14C-PL transfer to human HDL, since its partial inhibition by the anti-CETP antibody reduced significantly the 14C-PL transfer (p<0.05). However, comparing the nontransgenic (no CETP activity) with the CETP transgenic mouse plasma, no effect of CETP on the 14C-PL distribution in mice lipoproteins was observed.
        
        
          Conclusions
          It is concluded that: 1-intravascular lipases stimulate phospholipid transfer protein mediated phospholipid transfer, but not free cholesterol, from triglyceride rich particles to human high density lipoproteins and rat low density lipoproteins and high density lipoproteins; 2-free cholesterol and phospholipids are transferred from triglyceride rich particles to plasma lipoproteins by distinct mechanisms, and 3 - CETP also contributes to phospholipid transfer activity in human plasma but not in transgenic mice plasma, a species which has high levels of the specific phospholipid transfer protein activity.
Compound 528169: 1,3-Cyclopentadiene, 1-nonyl

Chemical compound data from PubChem database. IUPAC Name: 1-nonylcyclopenta-1,3-diene. Molecular Formula: C14H24. Molecular Weight: 192.34. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
2013 CMHS Uniform Reporting System (URS) Table for North Dakota

Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Tables for North Dakota for 2013. The Uniform Reporting System (URS) is a state and national reporting system collected annually to support the Community Mental Health Services Block Grant program.  State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
Program Instruction (PI-19-04)

This Program Instruction (PI) provides guidance to Indian Tribes, Indian Tribal Organizations and Indian Tribal Consortia (hereafter “tribes,” unless otherwise noted) on actions they are required to take to receive their allotments for Federal Fiscal Year (FY) 2020 (subject to the availability of appropriations) authorized under title IV-B, subparts 1 and 2, and Chafee and ETV programs.

PI-19-04 (PDF)

Fiscal Year 2018 Allotment Title IV-B Subpart 1 Stephanie Tubbs Jones Child Welfare Services
Fiscal Year 2018 Allotment Title IV-B Subpart 2 Promoting Safe and Stable Families
Fiscal Year 2018 Allotment for Chafee Foster Care Program for Successful Transition to Adulthood
Fiscal Year 2018 Allotment for Education and Training Vouchers

CFS-101 Instructions, Part I, II, and III Instructions

Part I: Annual Budget Request for Title IV-B, Subpart 1 & 2 Funds, Chafee, and ETV Instructions
Part II: Annual Estimated Expenditure Summary of Child and Family Services Instructions
Part III: Expenditures for Title IV-B, Subparts 1 and 2, Chafee Foster Care Independence (Chafee) and Education and Training Voucher (ETV) Programs Instructions

CFS-101 Forms, Parts I, II and III Excel Workbook (XLSX) (40 KB)

CFS-101 Forms Part I
CFS-101 Forms Part II
CFS-101 Forms Part III

Assurances and Certifications

Title IV-B, subpart 1 and 2 (PDF  (PDF)- 77 KB)
Chafee (PDF  (PDF)- 186 KB)
ETV (PDF  (PDF)- 102 KB)

CB Regional Program Managers

Notification of Adoption Savings Calculation Method

Annual Reporting of Education and Training Vouchers Awarded

Certification of Tribal Population Under Age 21

Tribal CFSP (Optional) Template for FYs 2020-2024 (Word  (DOCX)- 44 KB)

Tribal Training Plan (Optional) Template (Word  (DOCX)- 18 KB)

Metadata-only record linking to the original dataset. Open original dataset below.
Iowa 2016 Potential Areas for Addressing Service Gaps for Opioid Treatment

The purpose of the medication-assisted treatment (MAT) facility maps is to identify areas on a state-by-state basis that may be potentially underserved by existing treatment facilities. The maps are created with a methodology that seeks to include the highest potential need areas from individual counties so that county-level stakeholders are also informed. The maps are meant to be used as a tool for policy makers to determine potentially underserved areas—not as a definitive representation of these areas.
Nashville-Davidson-Murfreesboro-Franklin, TN

This report presents combined 2005 to 2010 National Survey on Drug Use and Health (NSDUH) results for those aged 12 or older in the Nashville-Davidson-Murfreesboro-Franklin, TN metro area. The report includes estimates of substance use disorder, major depressive episode, illicit drug use, marijuana use, cigarette use, binge alcohol use, and the nonmedical use of prescription-type pain relievers. Results are provided for the Nashville-Davidson-Murfreesboro-Franklin metro area, Tennessee, and the U.S. overall.
National Artesunate for Severe Malaria Program Case Report Data- April to December 2019

This dataset includes deidentified data on patients receiving artesunate through the National Artesunate for Severe Malaria Program from April- December 2019. 

This dataset contains the data from the case report form only.
Please see the links below for the other datasets and see the attached document 'Guide to NSAMP Datasets':
Data on Artesunate Dosing- https://data.cdc.gov/dataset/National-Artesunate-for-Severe-Malaria-Program-Art/qan4-gt4k
Data on Follow-On Antimalarial Dosing- https://data.cdc.gov/Global-Health/National-Artesunate-for-Severe-Malaria-Program-Fol/g3k9-gyw7
Data on Microscopy (Parasitemia values)- https://data.cdc.gov/Global-Health/National-Artesunate-for-Severe-Malaria-Program-Mic/v2k9-ctv4

All data can be easily linked using the ParticipantID field, a unique ID number assigned to each participant.
Expression of cytokine and chemokine mRNA and secretion of tumor necrosis factor-α by gallbladder epithelial cells: Response to bacterial lipopolysaccharides

Background
          In addition to immune cells, many other cell types are known to produce cytokines. Cultured normal mouse gallbladder epithelial cells, used as a model system for gallbladder epithelium, were examined for their ability to express the mRNA of various cytokines and chemokines in response to bacterial lipopolysaccharide. The synthesis and secretion of the tumor necrosis factor-α (TNF-α) protein by these cells was also measured.
        
        
          Results
          Untreated mouse gallbladder cells expressed mRNA for TNF-α, RANTES, and macrophage inflammatory protein-2 (MIP-2). Upon treatment with lipopolysaccharide, these cells now produced mRNA for Interleukin-1β (IL-1β), IL-6, monocyte chemoattractant protein-1 (MCP-1), and showed increased expression of TNF-α and MIP-2 mRNA. Untreated mouse gallbladder cells did not synthesize TNF-α protein; however, they did synthesize and secrete TNF-α upon treatment with lipopolysaccharide.
        
        
          Methods
          Cells were treated with lipopolysaccharides from 3 strains of bacteria. Qualitative and semi-quantitative RT-PCR, using cytokine or chemokine-specific primers, was used to measure mRNA levels of TNFα, IL-1β, IL-6, IL-10, KC, RANTES, MCP-1, and MIP-2. TNF-α protein was measured by immunoassays.
        
        
          Conclusion
          This research demonstrates that gallbladder epithelial cells in response to lipopolysaccharide exposure can alter their cytokine and chemokine RNA expression pattern and can synthesize and secrete TNFα protein. This suggests a mechanism whereby gallbladder epithelial cells in vivo may mediate gallbladder secretory function, inflammation and diseases in an autocrine/paracrine fashion by producing and secreting cytokines and/or chemokines during sepsis.
Behavioral Health Barometer: New York, 2014

This is a behavioral health report for the state of New York. It uses the  National Survey on Drug Use and Health (NSDUH) and the National Survey of Substance Abuse Treatment Services (NSSATS) to address the topics of youth substance use , youth mental health and treatment, adult mental health and treatment, substance use, substance use treatment, and medicare enrollees for the years 2009 to 2013.
2012 Uniform Reporting System (URS) Tables for Tennessee

Center for Mental Health Services (CMHS) Uniform Reporting System (URS) Output Tables for 2012. The Uniform Reporting System (URS) is a state and national reporting system collected annually to support the Community Mental Health Services Block Grant program. State Mental Health Authorities report on National Outcome Measures (NOMS), evidence based practices, and utilization measures providing an overview of state mental health delivery systems.
Compound 529781: Methyl 4-(3,4-methylenedioxyphenyl)butanoate

Chemical compound data from PubChem database. IUPAC Name: methyl 4-(1,3-benzodioxol-5-yl)butanoate. Molecular Formula: C12H14O4. Molecular Weight: 222.24. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
The missions of medical schools:

Mission statements and role documents of medical schools in the United Kingdom, United States, Canada and Australia have been examined on their Internet Web sites and categorised in purpose, content and presentation. The format and content are highly variable, but there is a common vision of three integral roles, namely, education, advancement of knowledge and service to society. Other frequent themes include tradition and historical perspective, service for designated communities, and benchmarking to accreditation standards. Differences in content reflect variable interpretation of the notion of "mission", and local or national characteristics such as institutional affiliations, the types, levels and organisation of medical education, relationships with health systems, and extent of multi-professional education. Outcomes data and measures of medical school performance referenced to the institution's stated missions are rarely encountered.
        Mission documents placed on the Internet are in the public domain. These Web sites and documents and linked information constitute a valuable new resource for international exchange of approaches and ideas in medical education and generally in academic medicine. Routine inclusion of outcome or performance data could help to demonstrate the community roles and social accountability of medical schools This paper proposes that partial standardisation of these Web documents could enhance their value both internally and for external readers. A generic descriptive statement template is offered.
Compound 525592: N,N-Dimethyl-N'-(4-chlorophenyl)-p-methoxybenzamidine

Chemical compound data from PubChem database. IUPAC Name: N'-(4-chlorophenyl)-4-methoxy-N,N-dimethylbenzenecarboximidamide. Molecular Formula: C16H17ClN2O. Molecular Weight: 288.77. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.
Pruritus: a useful sign for predicting the haemodynamic changes that occur following administration of vancomycin

Introduction
          The aim of this study was to investigate the haemodynamic changes that follow the appearance of pruritus during vancomycin administration.
        
        
          Methods
          We studied 50 patients scheduled for coronary artery bypass surgery, and we compared data from patients who exhibited pruritus with those from patients who did not. After the monitoring devices had been positioned, vancomycin (15 mg/kg) was continuously infused at a constant rate over 30 min, before induction of anaesthesia. Haemodynamic profiles were recorded before vancomycin infusion (time point 1); at 15 (time point 2) and 30 min (time point 3) after the beginning of vancomycin infusion; and 15 min after vancomycin infusion had been stopped (time point 4). At each time arterial and mixed venous blood samples were drawn to calculate the shunt fraction (Qsp/Qt).
        
        
          Results
          In patients who exhibited pruritus (group A, n = 17) at time point 3 versus time point 1, systemic vascular resistance index (SVRI) and arterial oxygen tension (PaO2) decreased significantly; cardiac index (CI), stroke volume index (SVI) and Qsp/Qt increased significantly; and mean systemic pressure and heart rate were stable. Those changes were observed only in patients not treated with a β-blocker before surgery, whereas no change occurred in patients treated with the drug. In the patients who were free from pruritus (group B, n = 28), we did not observe any significant change.
        
        
          Conclusion
          The appearance of pruritus during vancomycin administration indicates that SVRI is declining, thus exposing the patient to risk for hypotension. Therapy with a β-blocker appears to confer protection against this hemodynamic reaction.
Patent AT-E401696-T1: [Translated] WIRELESS TERMINAL

A wireless terminal having a dual band antenna arrangement which comprises a planar inverted-F antenna ( 10 ) having a first ( 12 ) for signals in a first, lower frequency band, for example the GSM band, a second feed ( 14 ) for signals in a second, higher frequency band, for example the DCS band, and a ground pin ( 16 ). A first coupling stage ( 26 A) couples the transmit and receive paths of a first transceiver (GSM) to the first feed and a second coupling stage ( 26 B) couples the transmit and receive paths of a second transceiver (DCS) to the second feed. Each of the first and second coupling stages comprise a quarter wavelength transmission line ( 50 A, 50 B) having a first end coupled to the respective transmit signal path and a second end coupled by band pass filter ( 52 A, 52 B) to the respective receive signal path. A first PIN diode (D 1 , D 3 ) couples a transmit signal path to the first end of the respective quarter wavelength transmission line and to the respective feed ( 12, 14 ) and a second PIN diode (D 2 , D 4 ) second end of the respective quarter wavelength transmission line to ground. In operation when transmitting in one of the bands, the first and second PIN diodes of the relevant coupling stage are switched-on, whilst the PIN diodes in the other coupling stage are off and when in a receiving mode all the PIN diodes are off. The signal being received by one of the transceivers is reflected by the band pass filter in the coupling stage of the other transceiver.
Patent AT-E399833-T1: [Translated] FLAME RETARDANT TREATMENT AGENTS, FLAME RETARDANT PROCESSING PROCESS AND FLAME RETARDANT ARTICLES

Flame retardant treating agents according to the invention comprise a phosphorus-based compound represented by the following formula (4): <CHEM> Flame retardant treated fibers can be obtained by immersion of polyester fiber woven fabrics and the like in a treatment solution containing the flame retardant treating agents and accomplishing heat treatment at a prescribed temperature. It is thereby possible to impart adequate flame retardance to polymer materials such as fibers and thermoplastic polymers even when used in small amounts, and provide flame retardant treating agents that contain no halogen compounds.
Hospital Equity Measures Reports

The data table would include information reported by hospitals in which the hospitals analyze access to and quality of care by age, sex, race, ethnicity, language, disability status, sexual orientation, gender identity, and socioeconomic status. These annual reports include measures of patient access, quality, and outcomes by race, ethnicity, language, disability status, sexual orientation, gender identity, and payor as recommended by the Hospital Equity Measures Advisory Committee (HEMAC). The reports also include a plan to prioritize and address disparities for vulnerable populations identified in the data and as specified by the HEMAC. Information will be made available in several formats, including Excel and PDF. Each reporting year, the data upload will include the following items:

Coversheet

Individual - General Acute care Hospital Reports (Excel format)

Individual - Children’s Hospital Reports (Excel format)

Individual - Acute Psychiatric Hospital Reports (Excel format)

System Level Reports (Excel format)

Individual Hospital Reports (PDF format)

System Level Reports (PDF format)
National Survey of Substance Abuse Treatment Services (N-SSATS-2004)

<p>The National Survey of Substance Abuse Treatment Services (N-SSATS) is designed to collect information from all facilities in the United States, both public and private, that provide substance abuse treatment. N-SSATS provides the mechanism for quantifying the dynamic character and composition of the United States substance abuse treatment delivery system. The objectives of N-SSATS are to collect multipurpose data that can be used to assist the Substance Abuse and Mental Health Services Administration (SAMHSA) and state and local governments in assessing the nature and extent of services provided and in forecasting treatment resource requirements, update SAMHSA's Inventory of Substance Abuse Treatment Services (I-SATS), analyze general treatment services trends, and generate the National Directory of Drug and Alcohol Abuse Treatment Programs and its online equivalent, the  Substance Abuse Treatment Facility Locator <a href="http://findtreatment.samhsa.gov">http://findtreatment.samhsa.gov</a>.<br />
Data are collected on topics including facility operation, services offered (assessment, substance abuse therapy and counseling, pharmacotherapies, testing, transitional, ancillary), primary focus (substance abuse, mental health, both, general health, other), hotline operation, Opioid Treatment Programs and medication dispensed/prescribed, languages in which treatment is provided, type of treatment provided, number of clients (total and under age 18), number of beds, types of payment accepted, sliding fee scale, special programs offered, facility accreditation and licensure/certification, and managed care agreements.This study has 1 Data Set.</p>
Compound 525625: N,N-Dimethyl-N'-decyl-p-methylbenzamidine

Chemical compound data from PubChem database. IUPAC Name: N'-decyl-N,N,4-trimethylbenzenecarboximidamide. Molecular Formula: C20H34N2. Molecular Weight: 302.5. This dataset contains comprehensive chemical information including structural data, physical properties, and biological activities. Useful for drug discovery, chemical research, and educational purposes.